Selzentry Faces Assay Challenge Even After Advisory Committee Thumbs Up

FDA will wrestle with how to include an unapproved diagnostic test in expanded labeling for Pfizer's HIV drug.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet